1760 Paon-Fu-Chin
NQ Score
50/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Paon-Fu-Chin announced that the active pharmaceutical ingredient (API) Ferric Citrate for its kidney disease drug 'Nephoxil' has been approved by the NMPA in China.
AI Analysis
Frequently Asked Questions
- Q: What is the main product of Paon-Fu-Chin?
- A: The kidney disease drug 'Nephoxil'.